Product
Odne is developing a portfolio of innovative products to fundamentally change how root canal treatments are done. Our goal is to set a new standard of care in endodontics.
Our new website with comprehensive product information is coming soon!
Are you a US dentist and want to be an early user?
Subscribe here to apply for our Priority Access Program:
The team
A success is almost never linked to an individual and we are proud of our achievements thanks to an amazing team. Discover our members in this section.
Barbara Hochstrasser
Quality Manager
Open Positions
Discover new vacanciesBoard of Directors
Our high-profile board ensures visionary management.
Discover more about our excellent leaders.
Andreas Meldau
President of the Board
Andreas holds a degree in Law from the University of Zurich and a postgraduate diploma in Management from St. Gallen. 37 years of experience in the field of healthcare, including 10 years of IT, 7 years of medical technology, and 20 years of dental. International management responsibility in the development and expansion of companies and organizations, both in the manufacturing and retail environment. Andreas supports Lumendo with his knowledge in the areas of project management, market development, sales channels, and contracts.
Simone Übele-Nascher
Member of the Board
Simone is a Managing Partner of ValCap Services, a M&A boutique and investment/start-up advisory. Previously, she worked at Acino International AG, a PE-backed international pharmaceutical company, in their Business Development and M&A department. Additional experience Simone gained in PwC’s M&A Advisory/Transaction Services and Management Consulting department. She holds a degree in Business and Automotive Engineering from University Stuttgart (Germany) and is a trained chartered accountant (ACCA). Her expertise in Business Development, M&A, Accounting, and Reporting is invaluable to us.
Andreas Schmocker
CEO & Co-Founder
Andreas has a background in Biomechanical Engineer, a PhD in applied photonics, and a minor in Management of Technology from the Swiss Federal Institute of Technology in Lausanne (EPFL). He is an expert in photopolymerization and medical device design. Andreas has founded and co-founded start-ups before in the field of IT and carbon offsetting. His key assets are his drive, long-term vision, and flexibility.
Mark Bispinghoff
COO & Co-Founder
Mark has a background in chemistry. He developed different methods to synthesize phosphorus-based photoinitiators during his PhD at the Swiss Federal Institute of Technology in Zürich (ETH). His methods are now used to synthesize optimized photoinitiators tailored to the application in different medical materials. His key assets are his tasked-focused attitude, chemical know-how and organizing skills.
Partners and advisors
Our university, venture and industry's partners were extremely precious since the beginning to assess, advice
and fuel our growth.
Our Precious Partners
Quality management system
At ODNE, the highest quality standards are essential to us.
Learn more about our ISO 13485 certification.
All media & press updated
DIA Announces Fifth Strategic Investment in Odne
January 19, 2024
We are greatful for the trust of DIA in Odne`s technology platform. DIA will be key to multiply Odne into the DSO market segment, the fastest growing dental segmenet in the US.
Second product cleared
November 24, 2023
We are happy to announce that we received clearance for our laser-based dental curing light (Odne®Cure) from the U.S. Food & Drug Administration
Odne announces the incorporation of its subsidiary Odne Inc in the US.
November 16, 2023
The incorporation of Odne Inc. marks an important milestone in the history of the company.
Lumendo changes its name
November 9, 2023
Lumendo AG is thrilled to announce a pivotal change in our company’s identity. Effective immediately, we have officially transitoned to Odne AG.
First product cleared
July 10, 2023
We have received clearance for our endodontic root canal filler from the U.S. Food & Drug Administration (FDA).
First clinical trial with successful results
October 10, 2022
Our first clinical trial of the cleaning and disinfection device from our revolutionary product range was successfully conducted in May leading up to 30% less post-operative pain.
Top 100 Startup in Switzerland
September 12, 2022
So proud to be recognized again as one of the TOP 100 Startups 2022. Many thanks to everyone of our team, partners and Venturelab believing in us along the way.
ODNE receives innosuisse certificate
September 8, 2022
We have been certified by the Swiss Innovation Agency as “ready for sustainable growth”, which is a great achievement.
Eurostars Grant won by TBD / Studio Mango / VEDS consortium
August 3, 2022
To us at Lumendo, international collaboration is essential for successful innovation. Therefore, receiving a prestigious Eurostars Grant is a great honour – together with our partners TBD Biodiscovery, Studio Mango and VEDS.
ISO Certificate achieved
June 13, 2022
At Lumendo, the highest quality standards are essential to us. Our quality management system has been successfully audited. We are now official allowed to develop, manufacturer and distribute devices and materials for dental root canal treatments.Click on the button below to see the complete certificate.
3.5 MCHF: Oversuscribed!
May 30, 2022
We are proud to announce that our 2.54 MCHF financing round was oversubscribed by 0.94 MCHF, reaching an astounding overall investment of 3.5 MCHF.
Appointment of new members to the Odne (former Lumendo) board of directors
February 16, 2022
Welcome to our new board members! We are happy to announce that Simone Übele-Näscher and Andreas Meldau have joined Lumendo in the quest for revolutionary endodontic treatments. Andreas Meldau was elected by the Lumendo board of directors as President of the board.
Odne (former Lumendo) closes 2.54 MCHF Seed financing round
January 7, 2022
We are very happy to announce the closing of our 2.54 MCHF seed financing round. The financing round was led by Dominik Lysek, PhD, partner at US-based Revere Partners. Co-investors were Zürich Cantonal Bank and Business Angels Switzerland.